Cart

0

Stocks

“These 2 Penny Stocks Could See Outsized Gains, Says Oppenheimer”

Outlook Therapeutics (OTLK)

Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, OLTK has a Strong Buy consensus rating. With the average price target clocking in at $6.33, the upside potential lands at 729%…

Organogenesis Holdings (ORGO)

All in all, other analysts echo Lichtman’s sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $8.67, the upside potential comes in at 126%…”

https://finance.yahoo.com/news/2-penny-stocks-could-see-193055850.html

Leave a Reply